Nifty
:
22461.00
Sensex
:
74157.54
58.60 (0.26%)
304.60 (0.41%)
Nifty
Sensex
:
:
22461.00
74157.54
58.60 (0.26%)
304.60 (0.41%)

Kilitch Drugs (India) Ltd.

Pharmaceuticals & Drugs

Rating :
64/99

BSE: 524500 | NSE: KILITCH

NSE BSE
346.30
24-Apr-2024
  • Open
  • High
  • Low
  • Previous Close
  •  355.00
  •  357.10
  •  344.55
  •  351.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  4457
  •  15.62
  •  470.00
  •  165.30

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 562.24
  • 38.59
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 581.60
  • N/A
  • 3.32

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 69.23%
  • 1.71%
  • 25.38%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 3.68%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 22.97
  • 11.10
  • 26.77

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 24.11
  • 27.27

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 29.56
  • 22.23
  • 41.74

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 38.15
  • 46.26
  • 38.33

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.64
  • 1.92
  • 2.25

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.93
  • 24.52
  • 23.19

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
31.79
29.97
6.07%
41.20
30.70
34.20%
36.56
33.45
9.30%
45.48
36.61
24.23%
Expenses
29.51
25.99
13.54%
32.58
26.74
21.84%
30.38
30.03
1.17%
39.26
31.56
24.40%
EBITDA
2.28
3.98
-42.71%
8.62
3.95
118.23%
6.18
3.42
80.70%
6.21
5.05
22.97%
EBIDTM
7.17%
13.28%
20.92%
12.88%
16.90%
10.22%
13.66%
13.79%
Other Income
2.96
0.69
328.99%
0.49
0.24
104.17%
0.56
0.97
-42.27%
1.02
0.38
168.42%
Interest
1.60
1.29
24.03%
1.51
1.75
-13.71%
1.50
0.67
123.88%
1.21
0.71
70.42%
Depreciation
0.82
0.93
-11.83%
0.82
0.89
-7.87%
0.79
0.82
-3.66%
0.91
1.13
-19.47%
PBT
2.82
2.45
15.10%
6.78
1.55
337.42%
4.45
2.90
53.45%
5.11
3.59
42.34%
Tax
1.08
0.74
45.95%
1.69
-0.38
-
1.39
1.16
19.83%
2.21
1.28
72.66%
PAT
1.74
1.71
1.75%
5.09
1.94
162.37%
3.06
1.74
75.86%
2.90
2.30
26.09%
PATM
5.48%
5.70%
12.36%
6.31%
8.37%
5.19%
6.38%
6.28%
EPS
1.81
1.52
19.08%
2.95
1.56
89.10%
2.15
1.34
60.45%
2.29
1.86
23.12%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 12
Net Sales
155.03
139.60
114.23
68.52
53.32
82.49
51.01
28.65
20.99
19.03
107.96
Net Sales Growth
18.59%
22.21%
66.71%
28.51%
-35.36%
61.71%
78.05%
36.49%
10.30%
-82.37%
 
Cost Of Goods Sold
79.75
74.76
65.43
37.31
29.09
48.17
26.00
11.25
8.73
7.02
71.19
Gross Profit
75.28
64.84
48.80
31.22
24.23
34.32
25.01
17.39
12.25
12.01
36.78
GP Margin
48.56%
46.45%
42.72%
45.56%
45.44%
41.61%
49.03%
60.70%
58.36%
63.11%
34.07%
Total Expenditure
131.73
121.87
103.73
63.21
53.33
76.47
45.71
29.20
25.29
20.79
95.34
Power & Fuel Cost
-
2.15
2.25
1.63
1.68
1.48
1.15
1.10
0.97
0.82
6.35
% Of Sales
-
1.54%
1.97%
2.38%
3.15%
1.79%
2.25%
3.84%
4.62%
4.31%
5.88%
Employee Cost
-
11.73
6.18
5.24
5.69
5.28
4.30
3.38
3.47
3.13
6.44
% Of Sales
-
8.40%
5.41%
7.65%
10.67%
6.40%
8.43%
11.80%
16.53%
16.45%
5.97%
Manufacturing Exp.
-
5.37
7.76
3.65
3.55
2.88
2.18
2.73
2.68
1.66
5.98
% Of Sales
-
3.85%
6.79%
5.33%
6.66%
3.49%
4.27%
9.53%
12.77%
8.72%
5.54%
General & Admin Exp.
-
8.73
6.46
5.71
6.32
4.78
3.27
2.80
2.71
2.52
2.04
% Of Sales
-
6.25%
5.66%
8.33%
11.85%
5.79%
6.41%
9.77%
12.91%
13.24%
1.89%
Selling & Distn. Exp.
-
14.81
11.42
7.22
6.20
8.64
5.22
4.71
3.46
2.00
2.02
% Of Sales
-
10.61%
10.00%
10.54%
11.63%
10.47%
10.23%
16.44%
16.48%
10.51%
1.87%
Miscellaneous Exp.
-
4.32
4.22
2.44
0.80
5.24
3.59
3.21
3.27
3.64
2.02
% Of Sales
-
3.09%
3.69%
3.56%
1.50%
6.35%
7.04%
11.20%
15.58%
19.13%
1.22%
EBITDA
23.29
17.73
10.50
5.31
-0.01
6.02
5.30
-0.55
-4.30
-1.76
12.62
EBITDA Margin
15.02%
12.70%
9.19%
7.75%
-0.02%
7.30%
10.39%
-1.92%
-20.49%
-9.25%
11.69%
Other Income
5.03
2.92
2.91
2.67
4.55
5.26
3.27
1.14
2.78
2.72
1.06
Interest
5.82
5.08
1.33
0.88
0.94
0.65
0.42
0.16
0.06
0.05
2.96
Depreciation
3.34
3.55
2.47
1.99
2.00
2.05
2.04
9.76
10.05
1.85
4.87
PBT
19.16
12.01
9.61
5.12
1.61
8.59
6.11
-9.32
-11.63
-0.95
5.84
Tax
6.37
3.73
3.40
1.35
0.77
4.76
0.96
-0.43
-0.44
-0.66
21.05
Tax Rate
33.25%
31.06%
35.38%
26.37%
47.83%
55.41%
15.71%
4.61%
3.78%
69.47%
21.62%
PAT
12.79
10.45
7.36
3.67
0.84
3.83
5.15
-8.89
-11.19
-0.29
76.87
PAT before Minority Interest
14.57
8.28
6.21
3.77
0.84
3.83
5.15
-8.89
-11.19
-0.29
76.31
Minority Interest
1.78
2.17
1.15
-0.10
0.00
0.00
0.00
0.00
0.00
0.00
0.56
PAT Margin
8.25%
7.49%
6.44%
5.36%
1.58%
4.64%
10.10%
-31.03%
-53.31%
-1.52%
71.20%
PAT Growth
66.32%
41.98%
100.54%
336.90%
-78.07%
-25.63%
-
-
-
-
 
EPS
7.94
6.49
4.57
2.28
0.52
2.38
3.20
-5.52
-6.95
-0.18
47.75

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 12
Shareholder's Funds
151.60
139.09
127.13
118.25
121.06
112.03
101.20
108.69
119.88
114.55
Share Capital
15.58
15.58
15.49
15.43
15.36
13.73
13.23
13.23
13.23
13.23
Total Reserves
130.66
120.65
111.28
101.63
104.58
94.56
86.59
94.08
105.27
99.94
Non-Current Liabilities
-1.91
-1.24
-0.90
-0.58
-0.62
-1.55
-2.47
-0.95
-0.51
0.82
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.04
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.07
0.28
0.38
0.39
0.41
0.00
0.00
0.00
0.00
0.00
Current Liabilities
68.87
69.28
73.32
21.97
20.09
14.92
11.69
7.99
6.85
60.47
Trade Payables
40.87
42.87
53.65
7.10
4.35
7.72
5.68
3.69
2.39
3.66
Other Current Liabilities
0.25
0.57
1.41
1.22
3.89
3.50
3.22
3.35
3.92
1.33
Short Term Borrowings
22.19
20.43
14.80
12.61
9.45
0.92
0.69
0.19
0.00
8.77
Short Term Provisions
5.56
5.41
3.45
1.04
2.40
2.78
2.11
0.77
0.55
46.71
Total Liabilities
217.54
208.34
201.90
141.86
142.63
126.13
110.42
115.73
126.22
176.92
Net Block
64.22
64.54
29.96
31.53
32.13
32.96
33.31
42.41
9.38
8.64
Gross Block
111.28
108.05
71.01
70.59
69.19
67.97
66.28
65.62
22.55
20.78
Accumulated Depreciation
47.06
43.51
41.05
39.06
37.06
35.01
32.97
23.21
13.16
12.14
Non Current Assets
91.14
94.23
121.53
86.08
77.75
63.14
61.85
68.43
79.48
9.61
Capital Work in Progress
3.62
3.16
65.48
29.60
20.25
3.18
0.66
0.00
0.00
0.00
Non Current Investment
22.66
23.93
23.88
24.05
25.02
26.00
27.01
25.82
47.16
0.72
Long Term Loans & Adv.
0.62
0.46
0.44
0.36
0.34
0.22
0.08
0.20
22.94
0.25
Other Non Current Assets
0.02
2.14
1.76
0.54
0.00
0.79
0.79
0.00
0.00
0.00
Current Assets
126.40
114.10
80.36
55.79
64.88
62.98
48.57
47.27
46.72
167.31
Current Investments
39.20
47.23
36.40
27.81
28.42
30.29
26.02
23.12
24.67
137.59
Inventories
2.04
5.00
3.59
5.56
4.72
2.80
2.60
2.62
2.38
2.30
Sundry Debtors
54.29
41.41
22.92
15.86
19.44
20.69
14.61
16.37
12.62
15.03
Cash & Bank
19.98
10.06
12.50
2.80
7.94
4.77
2.29
2.75
4.98
11.67
Other Current Assets
10.89
0.36
0.05
0.04
4.37
4.43
3.05
2.41
2.07
0.73
Short Term Loans & Adv.
10.35
10.04
4.91
3.73
4.21
4.07
2.98
2.38
2.00
0.22
Net Current Assets
57.53
44.83
7.05
33.81
44.78
48.07
36.87
39.28
39.87
106.84
Total Assets
217.54
208.33
201.89
141.87
142.63
126.12
110.42
115.73
126.23
176.92

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 12
Cash From Operating Activity
2.59
5.78
45.66
4.46
0.29
1.42
1.12
17.23
-7.62
-29.35
PBT
12.01
9.61
5.12
1.61
8.59
6.11
-9.32
-11.63
-0.95
-9.69
Adjustment
9.79
3.89
2.80
-1.23
1.87
2.03
11.49
9.17
2.08
7.15
Changes in Working Capital
-14.88
-5.19
38.75
6.33
-5.99
-6.70
-1.08
19.71
-8.70
-26.81
Cash after chg. in Working capital
6.92
8.32
46.67
6.71
4.47
1.44
1.09
17.25
-7.56
-29.35
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-4.33
-2.54
-1.01
-2.25
-4.18
-0.02
0.03
-0.02
-0.06
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
7.92
-15.25
-37.57
-10.45
-13.98
-4.45
-1.53
-19.57
-31.20
41.02
Net Fixed Assets
-3.54
-8.20
-0.42
-1.00
-1.67
-0.87
-0.66
-0.56
-2.00
96.84
Net Investments
7.08
-10.88
-8.42
1.58
0.88
-4.21
-4.10
-20.40
68.35
-138.00
Others
4.38
3.83
-28.73
-11.03
-13.19
0.63
3.23
1.39
-97.55
82.18
Cash from Financing Activity
-0.72
7.03
1.61
0.85
16.86
5.51
-0.04
0.11
-0.06
-9.49
Net Cash Inflow / Outflow
9.78
-2.44
9.70
-5.14
3.17
2.48
-0.45
-2.23
-38.87
2.18
Opening Cash & Equivalents
10.06
12.50
2.80
7.94
4.77
2.29
2.75
4.98
43.85
9.49
Closing Cash & Equivalent
19.85
10.06
12.50
2.80
7.94
4.77
2.29
2.75
4.98
11.67

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 12
Book Value (Rs.)
93.85
87.43
81.82
75.85
78.11
78.86
75.44
81.07
89.54
85.53
ROA
3.89%
3.03%
2.19%
0.59%
2.85%
4.36%
-7.86%
-9.25%
-0.19%
46.26%
ROE
5.86%
4.73%
3.09%
0.71%
3.36%
4.95%
-8.59%
-9.91%
-0.25%
78.03%
ROCE
10.26%
7.26%
4.40%
1.95%
7.59%
6.08%
-8.69%
-10.11%
-0.74%
76.95%
Fixed Asset Turnover
1.27
1.28
0.97
0.76
1.20
0.76
0.44
0.48
0.88
2.33
Receivable days
125.11
102.77
103.03
120.72
88.79
125.86
197.00
252.10
265.25
88.74
Inventory Days
9.21
13.72
24.29
35.14
16.62
19.22
33.17
43.50
44.88
31.91
Payable days
204.43
269.21
297.22
42.27
32.14
59.43
52.58
37.09
69.84
26.25
Cash Conversion Cycle
-70.11
-152.72
-169.89
113.59
73.27
85.65
177.59
258.51
240.30
94.40
Total Debt/Equity
0.15
0.15
0.12
0.11
0.08
0.01
0.01
0.00
0.00
0.08
Interest Cover
3.36
8.22
6.84
2.71
14.25
15.68
-58.98
-183.29
-17.71
33.88

Annual Reports:

FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012

News Update:


  • Kilitch Drug’s arm secures tender worth $9.13 million
    26th Feb 2024, 16:00 PM

    The contract awarded to Kilitch Estro Biotech PLC entails the supply of pharmaceuticals with an order size amounting to $9.13 million

    Read More
  • Kilitch Drugs(India) - Quarterly Results
    8th Feb 2024, 18:00 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.